Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences

Core Points - Regulus Therapeutics Inc. is participating in two upcoming investor conferences: Evercore 7th Annual HealthCONx Conference on December 3, 2024, and Piper Sandler 36th Annual Healthcare Conference on December 4, 2024 [1] - The live events and replays will be available on the company's investor relations website for 90 days following the presentations [1] Company Overview - Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing innovative medicines that target microRNAs [2] - The company has developed a pipeline supported by a strong intellectual property portfolio in the microRNA field and is headquartered in San Diego, CA [2]